Abstract:Background: We showed previously that global knockout (KO) of microRNA miR-204 attenuated hypertension but exacerbated renal injury including albuminuria in 14 days in C57BL/6J mice treated with uninephrectomy, angiotensin II, and a high-salt diet (Unx/AngII/salt). This suggests cell type-specific roles of miR-204. We hypothesize that miR-204 in podocytes protects against renal injury, specifically albuminuria via podocyte damage, in hypertension. Methods: We generated podocyte-specific miR-204 KO mice. Blood pressure and albuminuria were measured. RNA-seq in isolated miR-204 wild-type (WT) and KO mouse glomeruli, approximately 20% of which are podocytes, was performed. Human induced pluripotent stem cell-derived podocytes (iPSC-podocytes) were utilized to model and characterize podocyte injury. Results: Podocyte-specific miR-204 KO mice and WT littermates developed hypertension similarly following Unx/AngII/salt, but albuminuria was substantially exacerbated in miR-204 KO male mice (n=12, 8, 10 for WT, miR-204 +/- and miR-204 -/- , respectively; P<0.05, one-way ANOVA followed by Holm–Šidák test). RNA-seq analysis showed significant upregulation of Sox4, a target of miR-204 and a transcription factor promoting apoptotic p53, in the glomeruli of podocyte-specific miR-204 KO mice (P<0.05). A miR-204 KO iPSC line was generated by CRISPR/Cas9 and clonal expansion. Podocytes differentiated from miR-204 WT and KO iPSCs displayed arborized cell body, foot process-like structures, and significantly higher levels of podocyte markers Nphs1 and Nphs2. When apoptosis was induced via 24-hour AngII treatment, miR-204 KO iPSC-podocytes displayed upregulation of Sox4 (0.67±0.32 and 1.55±0.87, fold for WT and KO iPSC-podocytes compared to their control, n = 4, 4) and p53 (1.56±0.15 and 3.70±1.56, fold for WT and KO iPSC-podocytes compared to their control, n = 4, 4), and exacerbated AngII-induced apoptosis. Sox4 knockdown in miR-204 KO iPSC-podocytes mitigated the p53 upregulation (1.49±0.29 and 1.53±0.16, fold for WT and KO iPSC-podocytes compared to their control, n = 4, 4) and apoptosis. Conclusions: Our findings suggested that miR-204 in podocytes protect against AngII-induced apoptosis by suppressing Sox4, which in turn suppresses p53. Targeting the miR-204/Sox4 axis may hold therapeutic potential in attenuating podocyte injury and preserving renal function in hypertension patients.

Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy

Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice

[MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway]

Abstract P127: Microrna-204 Protects Against Angiotensin II-induced Apoptosis in Podocytes Via Sox4

MicroRNA-770-5p is Involved in the Development of Diabetic Nephropathy Through Regulating Podocyte Apoptosis by Targeting TP53 Regulated Inhibitor of Apoptosis 1.

miR-30a-5p targets Becn1 to ameliorate high-glucose-induced glomerular podocyte injury in immortalized rat podocyte cell line

miRNA-193a-mediated WT1 suppression triggers podocyte injury through activation of the EZH2/β-catenin/NLRP3 pathway in children with diabetic nephropathy

miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5

MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy

Inhibition of P53/miR‐34a Improves Diabetic Endothelial Dysfunction Via Activation of SIRT1

P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.

Inhibition of the Lncrna MIAT Prevents Podocyte Injury and Mitotic Catastrophe in Diabetic Nephropathy

MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.

Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis

miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4

MiR‐874 Alleviates Renal Injury and Inflammatory Response in Diabetic Nephropathy Through Targeting Toll‐like Receptor‐4

Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC‐1α mediated attenuation of mitochondrial oxidative stress

Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy

Puerarin Reduces Diabetic Nephropathy-Induced Podocyte Pyroptosis by Modulating the SIRT1/NLRP3/Caspase-1 Pathway

Podocyte SIRPα Reduction in Diabetic Nephropathy Aggravates Podocyte Injury by Promoting Pyruvate Kinase M2 Nuclear Translocation

miR-1187 induces podocyte injury and diabetic nephropathy through autophagy